Recent research from the **University of California, San Francisco** has employed machine learning techniques to uncover the neural and mental signatures associated with **schizophrenia**. This innovative...
Researchers at Lund University in Sweden have developed a groundbreaking method to convert the brain’s support cells into parvalbumin-positive cells. This innovative approach represents a significant...
On December 16, 2025, NetraMark Holdings Inc., a leader in artificial intelligence (AI) for clinical trials, announced a significant collaboration with the Centre for Addiction and...
Reviva Pharmaceuticals Inc. has made significant strides in developing a new treatment for schizophrenia, a complex brain disorder that affects approximately 24 million people worldwide, including...
Reviva Pharmaceuticals Inc. has made significant progress in the development of a novel drug aimed at treating schizophrenia, a complex brain disorder affecting approximately 24 million...
